Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norberto Perico

Showing results (151-160 of 202) with videos related to

Pageof 21
Sort By:
Stem Cells Translational Medicine|December 25, 2019
Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administrationFederica Casiraghi, Norberto Perico, Eliana Gotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2008
Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cellsFederica Casiraghi, Nadia Azzollini, Paola Cassis, et al.
Kidney International|February 12, 2004
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trialNorberto Perico, Piero Ruggenenti, Eliana Gotti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 2021
Albuminuria as a risk factor for mild cognitive impairment and dementia-what is the evidence?Boris Bikbov, Maria José Soler, Vesna Pešić, et al.
Frontiers in Medicine|May 9, 2022
A Home-Treatment Algorithm Based on Anti-inflammatory Drugs to Prevent Hospitalization of Patients With Early COVID-19: A Matched-Cohort Study (COVER 2)Elena Consolaro, Fredy Suter, Nadia Rubis, et al.
Eclinicalmedicine|June 15, 2021
A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: A retrospective observational matched-cohort studyFredy Suter, Elena Consolaro, Stefania Pedroni, et al.
Cytotherapy|February 18, 2022
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studiesChiara Capelli, Simona Frigerio, Daniela Lisini, et al.
Transplantation|November 9, 2007
Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injuryPiero Ruggenenti, Norberto Perico, Eliana Gotti, et al.
Kidney International|February 10, 2012
Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injuryPaola Cassis, Lorenzo Gallon, Ariela Benigni, et al.
Frontiers in Medicine|March 8, 2021
Bergamo and Covid-19: How the Dark Can Turn to LightNorberto Perico, Stefano Fagiuoli, Fabiano Di Marco, et al.
Pageof 21

Showing results (151-160 of 202) with videos related to

Sort By:
Pageof 21
Stem Cells Translational Medicine|December 25, 2019
Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administrationFederica Casiraghi, Norberto Perico, Eliana Gotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2008
Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cellsFederica Casiraghi, Nadia Azzollini, Paola Cassis, et al.
Kidney International|February 12, 2004
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trialNorberto Perico, Piero Ruggenenti, Eliana Gotti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 2021
Albuminuria as a risk factor for mild cognitive impairment and dementia-what is the evidence?Boris Bikbov, Maria José Soler, Vesna Pešić, et al.
Frontiers in Medicine|May 9, 2022
A Home-Treatment Algorithm Based on Anti-inflammatory Drugs to Prevent Hospitalization of Patients With Early COVID-19: A Matched-Cohort Study (COVER 2)Elena Consolaro, Fredy Suter, Nadia Rubis, et al.
Eclinicalmedicine|June 15, 2021
A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: A retrospective observational matched-cohort studyFredy Suter, Elena Consolaro, Stefania Pedroni, et al.
Cytotherapy|February 18, 2022
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studiesChiara Capelli, Simona Frigerio, Daniela Lisini, et al.
Transplantation|November 9, 2007
Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injuryPiero Ruggenenti, Norberto Perico, Eliana Gotti, et al.
Kidney International|February 10, 2012
Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injuryPaola Cassis, Lorenzo Gallon, Ariela Benigni, et al.
Frontiers in Medicine|March 8, 2021
Bergamo and Covid-19: How the Dark Can Turn to LightNorberto Perico, Stefano Fagiuoli, Fabiano Di Marco, et al.
Pageof 21